Briefing: Organocatalytic Strategy Provides a Metal-Free Route to Antiviral Candidates

A research team led by Prof. Sun Jianwei has introduced a novel air-stable chiral phosphine-catalyzed approach for the enantioselective synthesis of antiviral candidates.

This method emphasizes a metal-free route, which could streamline the production of enantioenriched S(IV)-stereogenic compounds.

The implications of this advancement are significant for both organic synthesis and medicinal chemistry, potentially enhancing throughput and efficiency in drug development.